Literature DB >> 21042337

Liver: Can pentoxifylline secure its place in liver therapeutics?

Stuart F W Kendrick1, Chris P Day.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21042337     DOI： 10.1038/nrgastro.2010.150

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor.

Authors:  U F Schade
Journal:  Circ Shock       Date:  1990-06

Review 2.  Review: regulation of liver regeneration by pro-inflammatory cytokines.

Authors:  A M Diehl; R Rai
Journal:  J Gastroenterol Hepatol       Date:  1996-05       Impact factor: 4.029

3.  Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis.

Authors:  T Soupison; S Yang; C Bernard; R Moreau; P Kirstetter; M D'Almeida; S Cailmail; A Tedgui; D Lebrec
Journal:  Clin Sci (Lond)       Date:  1996-07       Impact factor: 6.124

4.  Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline.

Authors:  R M Strieter; D G Remick; P A Ward; R N Spengler; J P Lynch; J Larrick; S L Kunkel
Journal:  Biochem Biophys Res Commun       Date:  1988-09-30       Impact factor: 3.575

5.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

6.  Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP.

Authors:  Y Katakami; Y Nakao; T Koizumi; N Katakami; R Ogawa; T Fujita
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

7.  Bacterial infection in the pathogenesis of variceal bleeding.

Authors:  J Goulis; D Patch; A K Burroughs
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

8.  Increased plasma tumor necrosis factor in severe alcoholic hepatitis.

Authors:  G L Bird; N Sheron; A K Goka; G J Alexander; R S Williams
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

9.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

Authors:  Nicholas C Boetticher; Craig J Peine; Paul Kwo; Gary A Abrams; Tushar Patel; Bashar Aqel; Lisa Boardman; Gregory J Gores; William S Harmsen; Craig J McClain; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2008-09-13       Impact factor: 22.682

10.  Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis.

Authors:  Didier Lebrec; Dominique Thabut; Frederic Oberti; Jean-Marc Perarnau; Bertrand Condat; Helene Barraud; Faouzi Saliba; Nicolas Carbonell; Philippe Renard; Marie-Jose Ramond; Richard Moreau; Thierry Poynard
Journal:  Gastroenterology       Date:  2010-01-25       Impact factor: 22.682
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.